NMD Pharma - PIR International
NMD Pharma A/S | LinkedIn
NMD Pharma
NMD Pharma on Twitter: "Today we welcome David Evans, Investment Director at the @Roche Venture Fund to the #NMDPharma #Board as Non-Executive Director. David brings decades of experience in the healthcare industry
NMD Pharma raises €35m to expand pipeline - European Pharmaceutical Manufacturer
NMD PHARMA APS innovation strategy - GoodIP
NMD Pharma Raises $39.7 Million to Advance Pipeline Targeting Rare Neuromuscular Disorders - Global Genes
NMD Pharma treats first patient with the firm's most promising drug candidate — MedWatch
NMD Pharma
News — NMD Pharma
NMD Pharma
NMD Pharma
NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech
Funding round-up: NMD Pharma, MindFi, Neo Medical, TargED Biopharmaceutical, MediBuddy - LaingBuisson News
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Lars J. S. Knutsen - VP, Medicinal Chemistry - NMD Pharma ApS | LinkedIn
Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire
NMD Pharma Raises €35M Financing - FinSMEs
NMD Pharma
NMD Pharma - PIR International
NMD Pharma Lights Up INCUBA/Skejby - Rare Disease Day 2023
Novo Seeds portfolio company NMD Pharma reports positive top-line Phase I/IIa data in myasthenia gravis - Startup Weekly
NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn
News — NMD Pharma
NMD Pharma (@NMDPharma) / Twitter
